Fundamentals-based quality & risk · not a recommendation
CLSL scores 39/100 (Caution) on the Orion Score — weak business quality (36), weak growth (42) and weak balance-sheet safety (42). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
—/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2025 | ₹200.43 | ₹5.6 | ₹17.01 | 5.5% |
| FY 2024 | ₹198.36 | ₹6.02 | ₹15.43 | 4.8% |
| FY 2023 | ₹131.22 | ₹4.07 | ₹12.37 | 6.4% |
| FY 2022 | ₹101.95 | ₹2.81 | ₹7.97 | 5.4% |
Q2 FY2026
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q2 FY2026 | 70.01% | — | — | 29.99% |
| Q4 FY2025 | 70.01% | — | — | 29.99% |
| Q2 FY2025 | 70.01% | — | — | 29.99% |
| Q4 FY2024 | 70.01% | — | — | 29.99% ↓ |
| Q2 FY2024 | 70.01% | — | — | 30% |
No recent corporate actions
Ask: "Is CLSL stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.